Getinge Group Shaping Health Care of tomorrow Net

Getinge Group

Shaping Health Care of tomorrow Net Sales 10. 9 billion SEK INFECTION CONTROL EXTENDED CARE Production units 10 Production units 5 Sales companies 25 Sales companies 24 Sales companies 23 MEDICAL SYSTEMS

Shaping Health Care of tomorrow

Infection Control- Fact sheet 2004 numbers Revenues EBITA margin 3, 524 MSEK 15. 2 %

Extended Care – Fact sheet 2004 Numbers Revenues EBITA margin 2, 701 MSEK 18. 9 %

Medical Systems – Fact sheet 2004 Numbers Revenues EBITA margin 4, 620 MSEK 15. 4 %

Getinge Group Development

Getinge has gained a competitive position in health care that will be further strengthened by current trends Increased co-payment Shift in power balance Technology breakthrough Fundamental increase in demand Financial deficits and unaffordabl e health care insurances Cost containment Increased use of competition Increased management of reimbursements Our customers in health care respond to the changes by…

Our customers in the healthcare industry respond Financial Targets to the changes by… n Health care policy makers will increasingly look for privatisation and market testing as tools to achieve cost efficiency n Activity based reimbursements continue to drive process efficiency n Focus on core competencies in medical processes n Elective care will be provided in outpatient facilities

Positive Outcomes A competent solution provider in well defined niches of the health care industry – offering solutions that enhance customers’ productivity over time

Strategic Cornerstones n Global leadership

Global leadership We strive to be a global No 1 or No 2 in the product areas focused. Market leadership will help us attain cost leadership through scale Infection Control Sterilization Disinfection No 1 Extended Care Patient Handling Hygiene Systems Wound Care No 1 No 4 Medical Systems Surgical Tables Surgical Lights Ceiling Pendants Cardiopulmonary Ventilation No 1 No 3 No 1

Strategic Cornerstones n Global leadership n Innovative solutions

Innovative Solutions We strive to combine the strength of our leading product positions and the depth of our know-how to offer innovative solutions that lead to process improvements for our customers Sterilization Disinfection Load Handling IT-systems Hygiene Systems Patient Handling Wound Care Surgical Tables Surgical Lights Pendants Integrated Infection Control solutions Integrated solutions for health care ergonomics Integrated solutions for surgical interventions

Competitive position Our competitive position will be based on cost leadership and innovations in solutions System Getinge Innovations Products Cost Innovation Leadership

Strategic Cornerstones n Global leadership n Innovative solutions n Direct Sales and Service approach

Direct Sales & Service Approach A direct approach to our customers is crucial to our succcess Getinge will strive to establish own distribution companies whenever justifiable n Solution provider n Transfer and exchange of know-how n Control all parameters that define customer satisfaction n Control the profitable after-sales market

Financial Targets Growth is the backbone of our development to remain a dynamic and attractive company and to fund our targeted expansion n Growth in pretax earnings > 15% p a n Cash-flow to sustain external growth rate > 10% p a

Results 1993 - 2004 CAGR 23%

Financial Targets by Business Area Target. A 2004 Organic growth EBITA margin 4 – 5 % ~ 16 % 15. 2 % Target. A 2004 Organic growth EBITA margin ~ 7 % ~ 19 % 18. 9 % Target. A 2004 Organic growth EBITA margin ~ 5 % ~ 17 % 15. 4 % GROUP Target A 2004 ~ 5 % + ~ 17 % + 16. 1 % Organic growth EBITA margin

2004 Financials

Getinge AB - Financials (MSEK) 2004 2003 Q 4 Orders received 2, 981 Net sales EBITA % EBIT % Profit before tax Change 2004 2003 12 Mon 2, 675 11% 10, 812 9, 154 18% 3, 477 2, 929 19% 10, 889 9, 160 19% 682 544 25% 1, 757 1, 449 21% 19. 6% 18. 6% 16. 1% 15. 8% 621 477 1, 505 1, 257 17. 9% 16. 3% 13. 8% 13. 7% 574 432 1, 309 1, 095 30% 33% Change 20%

Getinge AB - Key figures (MSEK) Operating Cash Flow, MSEK Net debt, MSEK Equity / Assets ratio, % Net debt / Equity ratio, multiple Interest cover, multiple 2004 2003 Q 4 12 Mon 1, 878 1, 980 4, 705 4, 852 33. 1% 29. 3% 1. 18 1. 37 7. 1 7. 3 584 556

Strategy for Growth The Getinge group will reach its growth targets by: n Development of existing positions u Organic growth u Bolt-on acquisitions n Acquisitions of new globally leading product lines that will strengthen our position as an innovative provider of solutions

Strategy for growth 2004 – 2007 Infection Control Principally organic growth supplemented by bolt-on acquisitions to reach new geographical territories, add new technologies in existing product lines n Strengthen solution provider capabilities n Focused approach towards the global Life Science industry n Geographical expansion n Continue to strengthen competitiveness through improved production structure and logistics

Strategy for growth 2004 – 2007 Extended Care Principally organic growth on existing markets supplemented by bolt-on acquisitions to add new technologies in existing product lines n Total bed-side management in elderly care n Enter the hospital market / bariatric care n Improved supply chain for increased competitiveness

Strategy for growth 2004 – 2007 Medical Systems Organic growth on existing markets and existing product lines Acquisitions of new globally leading product lines that will strengthen our position as an innovative solution provider with special emphasis on critical care and cardiac surgery n Position as provider of integrated solutions n Strengthen sales network in developing economies and North America n Continue to strengthen product leadership position n Develop Critical Care product portfolio through acquisitions

Solid base - bright future Getinge has gained a competitive position in its market that will be further strengthened by current trends Infection Control is positioned to achieve solid organic growth over coming years. Efforts and activities to improve the production structure and logistics will strengthen competitiveness Extended Care is establishing a product portfolio capable of delivering higher levels of organic growth. The hospital market for ergonomic solutions is an untapped opportunity that will be addressed Medical Systems has created a strong base for continued external expansion in a dynamic environment. Significant scope for organic growth on emerging markets and in North America